## Supplementary material


### Top latent variables associated with neutrophils

::: {style="color: red"}
**NOT FINISHED**

This section aims to show that the top LVs related to neutrophil counts are more correlated to neutrophil counts or esimates than expected by chance.
Probably I just need to add a proper caption for each figure, and reference them from the main text.
:::

![
**Correlation of neutrophil counts with top LVs associated with neutrophils traits.**
<!-- Description -->
](images/supplementary_material/lv603_neutrophils/neutrophils_top20_lvs.png "Top
20 LVs associated with neutrophils"){#fig:supp:neutrophils_top20lvs}

![
**Significance of neutrophil counts correlation.**
<!-- Description -->
](images/supplementary_material/lv603_neutrophils/significance_neutrophil.png "Significance of neutrophil counts
correlation"){#fig:supp:signif_neutrophils_counts height=3in}


### LV116 cell types

![
**Cell types for LV116.**
<!--  -->
](images/lvs_analysis/lv116/lv116-cell_types.png "Cell types for LV116"){#fig:sup:lv116 width="80%"}


### LV931 cell types

![
**Cell types for LV931.**
<!--  -->
](images/lvs_analysis/lv931/lv931-cell_types.png "Cell types for LV931"){#fig:sup:lv931 width="80%"}


### LV536 cell types

![
**Cell types for LV536.**
<!--  -->
FIXME: *transitional* here refers to bladder: https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP007947
<!--  -->
](images/lvs_analysis/lv536/lv536-cell_types.png "Cell types for LV536"){#fig:sup:lv536 width="80%"}


### LV885 cell types

![
**Cell types for LV885.**
<!--  -->
](images/lvs_analysis/lv885/lv885-tissues.png "Cell types for LV885"){#fig:sup:lv885 width="80%"}


### LV840 cell types

![
**Cell types for LV840.**
<!--  -->
](images/lvs_analysis/lv840/lv840-cell_types.png "Cell types for LV840"){#fig:sup:lv840 width="80%"}


### LV66 cell types

![
**Cell types for LV66.**
<!--  -->
](images/lvs_analysis/lv66/lv66-cell_types.png "Cell types for LV66"){#fig:sup:lv66 width="80%"}


### LV21

![
**Cell types for LV21.**
<!--  -->
](images/lvs_analysis/lv21/lv21-cell_types.svg "Cell types for LV21"){#fig:sup:lv21 width="80%"}

<!-- LV21:phenomexcan_traits_assocs:start -->
| Trait description   | Sample size   | Cases   | Partition/cluster number   | p-value (adjusted)   |
|:--------------------|:--------------|:--------|:---------------------------|:---------------------|
| Alzheimers Disease  | 54,162        | 17,008  | 29 / 16                    | 1.64e-19             |
| LDL Cholesterol NMR | 13,527        |         | 29 / 16                    | 1.18e-04             |
| Triglycerides NMR   | 21,559        |         | 29 / 16                    | 2.19e-02             |

Table: Significant trait associations of LV21 in PhenomeXcan. {#tbl:sup:phenomexcan_assocs:lv21}
<!-- LV21:phenomexcan_traits_assocs:end -->

<!-- LV21:emerge_traits_assocs:start -->
| Phecode   | Trait description        | Sample size   | Cases   | p-value (adjusted)   |
|:----------|:-------------------------|:--------------|:--------|:---------------------|
| 573       | Other disorders of liver | 47,826        | 2,524   | 1.37e-02             |
| 577       | Diseases of pancreas     | 60,538        | 1,795   | 2.15e-02             |

Table: Significant trait associations of LV21 in eMERGE. {#tbl:sup:emerge_assocs:lv21}
<!-- LV21:emerge_traits_assocs:end -->


### LV5

![
**Cell types for LV5.**
<!--  -->
](images/lvs_analysis/lv5/lv5-cell_types.svg "Cell types for LV5"){#fig:sup:lv5 width="80%"}

<!-- LV5:phenomexcan_traits_assocs:start -->
| Trait description                                                                      | Sample size   | Cases   | Partition/cluster number   | p-value (adjusted)   |
|:---------------------------------------------------------------------------------------|:--------------|:--------|:---------------------------|:---------------------|
| LDL Cholesterol NMR                                                                    | 13,527        |         | 29 / 16                    | 1.78e-04             |
| Triglycerides NMR                                                                      | 21,559        |         | 29 / 16                    | 5.00e-04             |
| Alzheimers Disease                                                                     | 54,162        | 17,008  | 29 / 16                    | 3.06e-03             |
| Ever had prolonged feelings of sadness or depression                                   | 117,763       | 64,374  | 29 / 27                    | 8.69e-03             |
| Substances taken for depression: Medication prescribed to you (for at least two weeks) | 117,763       | 28,351  | 29 / 27                    | 1.03e-02             |
| Recent feelings of depression                                                          | 117,656       |         | 29 / 27                    | 1.32e-02             |
| Ever contemplated self-harm                                                            | 117,610       |         | 29 / 27                    | 1.89e-02             |
| Recent lack of interest or pleasure in doing things                                    | 117,757       |         | 29 / 27                    | 2.08e-02             |
| Amount of alcohol drunk on a typical drinking day                                      | 108,256       |         | 29 / 27                    | 3.50e-02             |
| Ever sought or received professional help for mental distress                          | 117,677       | 46,020  | 29 / 27                    | 3.92e-02             |
| General happiness                                                                      | 117,442       |         | 29 / 27                    | 4.74e-02             |

Table: Significant trait associations of LV5 in PhenomeXcan. {#tbl:sup:phenomexcan_assocs:lv5}
<!-- LV5:phenomexcan_traits_assocs:end -->

<!-- LV5:emerge_traits_assocs:start -->
| Phecode   | Trait description            | Sample size   | Cases   | p-value (adjusted)   |
|:----------|:-----------------------------|:--------------|:--------|:---------------------|
| 241       | Nontoxic nodular goiter      | 47,842        | 3,158   | 8.98e-03             |
| 241.1     | Nontoxic uninodular goiter   | 47,125        | 2,441   | 2.57e-02             |
| 241.2     | Nontoxic multinodular goiter | 46,465        | 1,781   | 4.43e-02             |

Table: Significant trait associations of LV5 in eMERGE. {#tbl:sup:emerge_assocs:lv5}
<!-- LV5:emerge_traits_assocs:end -->


### LV434

![
**Cell types for LV434.**
<!--  -->
`FIXME:`{.red} put this in each figure
The top samples in human breast cancer cells have larger LV values that were thresholded at 3.0 for visualization purposes.
<!--  -->
HEK293 is a cell line derived from human embryonic kidney cells;
3T3 is a cell line derived from mouse embryonic fibroblasts.
](images/lvs_analysis/lv434/lv434-cell_types.svg "Cell types for LV434"){#fig:sup:lv434 width="80%"}

<!-- LV434:phenomexcan_traits_assocs:start -->
| Trait description                        | Sample size   | Cases   | Partition/cluster number   | p-value (adjusted)   |
|:-----------------------------------------|:--------------|:--------|:---------------------------|:---------------------|
| Attention Deficit Hyperactivity Disorder | 53,293        | 19,099  | 29 / 21                    | 7.01e-03             |

Table: Significant trait associations of LV434 in PhenomeXcan. {#tbl:sup:phenomexcan_assocs:lv434}
<!-- LV434:phenomexcan_traits_assocs:end -->

<!-- LV434:emerge_traits_assocs:start -->
| Phecode   | Trait description                        | Sample size   | Cases   | p-value (adjusted)   |
|:----------|:-----------------------------------------|:--------------|:--------|:---------------------|
| 722       | Intervertebral disc disorders            | 47,659        | 7,458   | 6.65e-03             |
| 721       | Spondylosis and allied disorders         | 47,517        | 7,316   | 7.62e-03             |
| 250.4     | Abnormal glucose                         | 45,220        | 4,947   | 1.02e-02             |
| 721.1     | Spondylosis without myelopathy           | 47,315        | 7,114   | 1.22e-02             |
| 720       | Spinal stenosis                          | 44,807        | 4,606   | 1.74e-02             |
| 288       | Diseases of white blood cells            | 47,288        | 2,802   | 2.10e-02             |
| 796       | Elevated prostate specific antigen [PSA] | 51,990        | 2,175   | 3.09e-02             |
| 288.2     | Elevated white blood cell count          | 46,595        | 2,109   | 3.54e-02             |
| 079       | Viral infection                          | 46,991        | 1,934   | 4.19e-02             |

Table: Significant trait associations of LV434 in eMERGE. {#tbl:sup:emerge_assocs:lv434}
<!-- LV434:emerge_traits_assocs:end -->


### LV136

![
**Cell types for LV136.**
<!--  -->
Pulmonary microvascular endothelial cells were exposed to hypoxia for 24 hours or more [@url:https://www.ncbi.nlm.nih.gov/bioproject/PRJNA232177];
](images/lvs_analysis/lv136/lv136-cell_types.svg "Cell types for LV136"){#fig:sup:lv136 width="80%"}

<!-- LV136:phenomexcan_traits_assocs:start -->
| Trait description                                                          | Sample size   | Cases   | Partition/cluster number   | p-value (adjusted)   |
|:---------------------------------------------------------------------------|:--------------|:--------|:---------------------------|:---------------------|
| 3mm strong meridian (right)                                                | 75,410        |         | 29 / 10                    | 9.19e-11             |
| 6mm strong meridian (left)                                                 | 65,551        |         | 29 / 10                    | 2.06e-09             |
| 6mm strong meridian (right)                                                | 66,256        |         | 29 / 10                    | 2.38e-09             |
| 3mm strong meridian (left)                                                 | 75,398        |         | 29 / 10                    | 1.34e-08             |
| 3mm weak meridian (right)                                                  | 75,410        |         | 29 / 10                    | 1.67e-08             |
| Coronary Artery Disease                                                    | 184,305       | 60,801  | 29 / 11                    | 1.67e-08             |
| 6mm weak meridian (right)                                                  | 66,256        |         | 29 / 10                    | 3.21e-08             |
| 3mm weak meridian (left)                                                   | 75,398        |         | 29 / 10                    | 5.20e-08             |
| 6mm weak meridian (left)                                                   | 65,551        |         | 29 / 10                    | 1.21e-07             |
| Coronary atherosclerosis                                                   | 361,194       | 14,334  | 29 / 14                    | 3.90e-06             |
| Ischaemic heart disease, wide definition                                   | 361,194       | 20,857  | 29 / 14                    | 7.22e-06             |
| Vascular/heart problems diagnosed by doctor: Heart attack                  | 360,420       | 8,288   | 29 / 14                    | 2.93e-04             |
| Myocardial infarction                                                      | 361,194       | 7,018   | 29 / 14                    | 6.33e-04             |
| Myocardial infarction, strict                                              | 361,194       | 7,018   | 29 / 14                    | 6.33e-04             |
| Diagnoses - main ICD10: I21 Acute myocardial infarction                    | 361,194       | 5,948   | 29 / 14                    | 9.92e-04             |
| Non-cancer illness code, self-reported: heart attack/myocardial infarction | 361,141       | 8,239   | 29 / 14                    | 1.40e-03             |
| Major coronary heart disease event excluding revascularizations            | 361,194       | 10,157  | 29 / 14                    | 1.85e-02             |
| Major coronary heart disease event                                         | 361,194       | 10,157  | 29 / 14                    | 1.85e-02             |
| Fasting Insulin                                                            | 38,238        |         | 29 / 11                    | 3.85e-02             |

Table: Significant trait associations of LV136 in PhenomeXcan. {#tbl:sup:phenomexcan_assocs:lv136}
<!-- LV136:phenomexcan_traits_assocs:end -->

<!-- LV136:emerge_traits_assocs:start -->
| Phecode   | Trait description            | Sample size   | Cases   | p-value (adjusted)   |
|:----------|:-----------------------------|:--------------|:--------|:---------------------|
| 747.1     | Cardiac congenital anomalies | 59,198        | 1,871   | 4.71e-02             |
| 411.4     | Coronary atherosclerosis     | 52,836        | 13,715  | 4.80e-02             |

Table: Significant trait associations of LV136 in eMERGE. {#tbl:sup:emerge_assocs:lv136}
<!-- LV136:emerge_traits_assocs:end -->


### Agreement of consensus clustering partitions with the ensemble by number of clusters

![
**Final selected partitions for follow-up analysis.**
<!--  -->
From all consensus clustering partitions generated with $k$ from 2 to 60, we selected those with a median adjusted Rand index (ARI) with the ensemble members greater the 75th percentile.
](images/clustering/selected_best_partitions_by_k.svg "Consensus partitions agreement with ensemble"){#fig:sup:consensus_agreement width="80%"}


### Gene modules that differentiate clusters of traits

![
**Gene modules show specific and general transcriptional processes associated with different clusters of traits.**
<!--  -->
`(Early draft version; we need to improve the y-axis labels on the right)`{.red}
<!--  -->
The plot shows a submatrix of $\hat{\mathbf{M}}$ for the main trait clusters (from the bottom of the clustering tree in Figure @fig:clustering:tree), considering only gene modules (rows) that align well with at least one known pathway.
Labels on the right show the top two cell types and top two tissues where gene modules are expressed in.
Values range from -5 (lighter color) to 16 (darker color).
<!--  -->
](images/clustering/global_clustermap-cell_types.svg "Heatmap with gene modules and traits"){#fig:clustering:heatmap width="100%"}


![
**Pathways associated with gene modules in Figure @fig:clustering:heatmap.**
<!--  -->
`(Early draft version; instead of this figure, we might want to just add a table with information about LVs)`{.red}
<!--  -->
This figure is equivalent to Figure @fig:clustering:heatmap but, instead of cell types, labels on the right show all the associated pathways for each latent variable.
<!--  -->
](images/clustering/global_clustermap-pathways.svg "Heatmap with gene modules and traits"){#fig:clustering:heatmap_pathways width="100%"}
